Suggested Dosing
Oil
Arthritis: 5-20% in an oil-based formulation or 5-10% in an alcohol-based formulation
Nasal Congestion: 1 tsp in boiling water for steam inhalation; also rub on chest & around nose
Suggested Uses
Arthritis, nasal congestion, asthma, skin ulcers, tick repellant
Interactions
Interaction Checker
No Results

Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor

Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (14)
- carbamazepine
carbamazepine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- cimetidine
cimetidine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- clarithromycin
clarithromycin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- erythromycin base
erythromycin base will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- erythromycin ethylsuccinate
erythromycin ethylsuccinate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- erythromycin lactobionate
erythromycin lactobionate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- erythromycin stearate
erythromycin stearate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- fluorouracil
eucalyptus increases levels of fluorouracil by Other (see comment). Use Caution/Monitor. Comment: Applies to topical preparations only. Mechanism: enhanced transdermal absorption.
- ketoconazole
ketoconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- levoketoconazole
levoketoconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- rifabutin
rifabutin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- rifampin
rifampin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- St John's Wort
St John's Wort will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
- topiramate
eucalyptus and topiramate both increase sedation. Use Caution/Monitor.
Minor (237)
- acarbose
eucalyptus increases effects of acarbose by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- albuterol
eucalyptus increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- alfentanil
alfentanil and eucalyptus both increase sedation. Minor/Significance Unknown.
- alprazolam
alprazolam and eucalyptus both increase sedation. Minor/Significance Unknown.
- amitriptyline
amitriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.
- amobarbital
amobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
amobarbital and eucalyptus both increase sedation. Minor/Significance Unknown. - amoxapine
amoxapine and eucalyptus both increase sedation. Minor/Significance Unknown.
- apomorphine
apomorphine and eucalyptus both increase sedation. Minor/Significance Unknown.
- aprepitant
aprepitant will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- arformoterol
eucalyptus increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- aripiprazole
aripiprazole and eucalyptus both increase sedation. Minor/Significance Unknown.
- armodafinil
armodafinil will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
eucalyptus increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown. - artemether/lumefantrine
artemether/lumefantrine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- atazanavir
atazanavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- azelastine
azelastine and eucalyptus both increase sedation. Minor/Significance Unknown.
- baclofen
baclofen and eucalyptus both increase sedation. Minor/Significance Unknown.
- belladonna and opium
belladonna and opium and eucalyptus both increase sedation. Minor/Significance Unknown.
- benperidol
benperidol and eucalyptus both increase sedation. Minor/Significance Unknown.
- benzphetamine
eucalyptus increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- bosentan
bosentan will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- brompheniramine
brompheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- budesonide
budesonide will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- buprenorphine
buprenorphine and eucalyptus both increase sedation. Minor/Significance Unknown.
- buprenorphine buccal
buprenorphine buccal and eucalyptus both increase sedation. Minor/Significance Unknown.
- butabarbital
butabarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
butabarbital and eucalyptus both increase sedation. Minor/Significance Unknown. - butalbital
butalbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
butalbital and eucalyptus both increase sedation. Minor/Significance Unknown. - butorphanol
butorphanol and eucalyptus both increase sedation. Minor/Significance Unknown.
- caffeine
eucalyptus increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- calcium/magnesium/potassium/sodium oxybates
eucalyptus and calcium/magnesium/potassium/sodium oxybates both increase sedation. Minor/Significance Unknown.
- carbinoxamine
carbinoxamine and eucalyptus both increase sedation. Minor/Significance Unknown.
- carisoprodol
carisoprodol and eucalyptus both increase sedation. Minor/Significance Unknown.
- chloral hydrate
chloral hydrate and eucalyptus both increase sedation. Minor/Significance Unknown.
- chlordiazepoxide
chlordiazepoxide and eucalyptus both increase sedation. Minor/Significance Unknown.
- chlorpheniramine
chlorpheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- chlorpromazine
chlorpromazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- chlorpropamide
eucalyptus increases effects of chlorpropamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- chlorzoxazone
chlorzoxazone and eucalyptus both increase sedation. Minor/Significance Unknown.
- cinnarizine
cinnarizine and eucalyptus both increase sedation. Minor/Significance Unknown.
- clemastine
clemastine and eucalyptus both increase sedation. Minor/Significance Unknown.
- clomipramine
clomipramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- clonazepam
clonazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- clorazepate
clorazepate and eucalyptus both increase sedation. Minor/Significance Unknown.
- clozapine
clozapine and eucalyptus both increase sedation. Minor/Significance Unknown.
- codeine
codeine and eucalyptus both increase sedation. Minor/Significance Unknown.
- conivaptan
conivaptan will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- cortisone
cortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- cyclizine
cyclizine and eucalyptus both increase sedation. Minor/Significance Unknown.
- cyclobenzaprine
cyclobenzaprine and eucalyptus both increase sedation. Minor/Significance Unknown.
- cyclosporine
cyclosporine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- cyproheptadine
cyproheptadine and eucalyptus both increase sedation. Minor/Significance Unknown.
- dantrolene
dantrolene and eucalyptus both increase sedation. Minor/Significance Unknown.
- darifenacin
darifenacin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- darunavir
darunavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- dasatinib
dasatinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- desipramine
desipramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- dexamethasone
dexamethasone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- dexchlorpheniramine
dexchlorpheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- dexfenfluramine
eucalyptus increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- dexmedetomidine
dexmedetomidine and eucalyptus both increase sedation. Minor/Significance Unknown.
- dexmethylphenidate
eucalyptus increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- dextroamphetamine
eucalyptus increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- dextromoramide
dextromoramide and eucalyptus both increase sedation. Minor/Significance Unknown.
- DHEA, herbal
DHEA, herbal will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- diamorphine
diamorphine and eucalyptus both increase sedation. Minor/Significance Unknown.
- diazepam
diazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- diethylpropion
eucalyptus increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- difenoxin hcl
difenoxin hcl and eucalyptus both increase sedation. Minor/Significance Unknown.
- dimenhydrinate
dimenhydrinate and eucalyptus both increase sedation. Minor/Significance Unknown.
- diphenhydramine
diphenhydramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- diphenoxylate hcl
diphenoxylate hcl and eucalyptus both increase sedation. Minor/Significance Unknown.
- dipipanone
dipipanone and eucalyptus both increase sedation. Minor/Significance Unknown.
- dobutamine
eucalyptus increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- dopamine
eucalyptus increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- dopexamine
eucalyptus increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- doxepin
doxepin and eucalyptus both increase sedation. Minor/Significance Unknown.
- doxylamine
doxylamine and eucalyptus both increase sedation. Minor/Significance Unknown.
- dronedarone
dronedarone will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- droperidol
droperidol and eucalyptus both increase sedation. Minor/Significance Unknown.
- efavirenz
efavirenz will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- ephedrine
eucalyptus increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- epinephrine
eucalyptus increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- epinephrine racemic
eucalyptus increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- eslicarbazepine acetate
eslicarbazepine acetate will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- estazolam
estazolam and eucalyptus both increase sedation. Minor/Significance Unknown.
- ethanol
ethanol and eucalyptus both increase sedation. Minor/Significance Unknown.
- etomidate
etomidate and eucalyptus both increase sedation. Minor/Significance Unknown.
- etravirine
etravirine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- fenfluramine
eucalyptus increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- fluconazole
fluconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- fludrocortisone
fludrocortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- fluphenazine
fluphenazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- flurazepam
flurazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- formoterol
eucalyptus increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- fosamprenavir
fosamprenavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- fosaprepitant
fosaprepitant will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- fosphenytoin
fosphenytoin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- glimepiride
eucalyptus increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- glipizide
eucalyptus increases effects of glipizide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- glyburide
eucalyptus increases effects of glyburide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- grapefruit
grapefruit will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- griseofulvin
griseofulvin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- haloperidol
haloperidol and eucalyptus both increase sedation. Minor/Significance Unknown.
- hydrocortisone
hydrocortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- hydromorphone
hydromorphone and eucalyptus both increase sedation. Minor/Significance Unknown.
- hydroxyzine
hydroxyzine and eucalyptus both increase sedation. Minor/Significance Unknown.
- iloperidone
iloperidone and eucalyptus both increase sedation. Minor/Significance Unknown.
- imipramine
imipramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- indinavir
indinavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- insulin aspart
eucalyptus increases effects of insulin aspart by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin detemir
eucalyptus increases effects of insulin detemir by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin glargine
eucalyptus increases effects of insulin glargine by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin glulisine
eucalyptus increases effects of insulin glulisine by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin lispro
eucalyptus increases effects of insulin lispro by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin NPH
eucalyptus increases effects of insulin NPH by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- insulin regular human
eucalyptus increases effects of insulin regular human by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- isoniazid
isoniazid will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- isoproterenol
eucalyptus increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- ketotifen, ophthalmic
eucalyptus and ketotifen, ophthalmic both increase sedation. Minor/Significance Unknown.
- lapatinib
lapatinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- levalbuterol
eucalyptus increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- levoketoconazole
eucalyptus will decrease the level or effect of levoketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- levorphanol
levorphanol and eucalyptus both increase sedation. Minor/Significance Unknown.
- lisdexamfetamine
eucalyptus increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- lofepramine
lofepramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- lofexidine
eucalyptus and lofexidine both increase sedation. Minor/Significance Unknown.
- loprazolam
loprazolam and eucalyptus both increase sedation. Minor/Significance Unknown.
- lorazepam
lorazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- lormetazepam
lormetazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- loxapine
loxapine and eucalyptus both increase sedation. Minor/Significance Unknown.
- loxapine inhaled
loxapine inhaled and eucalyptus both increase sedation. Minor/Significance Unknown.
- lumefantrine
lumefantrine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- maprotiline
maprotiline and eucalyptus both increase sedation. Minor/Significance Unknown.
- marijuana
marijuana will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
eucalyptus and marijuana both increase sedation. Minor/Significance Unknown. - melatonin
eucalyptus and melatonin both increase sedation. Minor/Significance Unknown.
- meperidine
meperidine and eucalyptus both increase sedation. Minor/Significance Unknown.
- meprobamate
eucalyptus and meprobamate both increase sedation. Minor/Significance Unknown.
- metaproterenol
eucalyptus increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- metaxalone
metaxalone and eucalyptus both increase sedation. Minor/Significance Unknown.
- metformin
eucalyptus increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- methadone
methadone and eucalyptus both increase sedation. Minor/Significance Unknown.
- methamphetamine
eucalyptus increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- methocarbamol
methocarbamol and eucalyptus both increase sedation. Minor/Significance Unknown.
- methylenedioxymethamphetamine
eucalyptus increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- methylprednisolone
methylprednisolone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- metronidazole
metronidazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- miconazole vaginal
miconazole vaginal will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- midazolam
midazolam and eucalyptus both increase sedation. Minor/Significance Unknown.
- midodrine
eucalyptus increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- miglitol
eucalyptus increases effects of miglitol by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- mirtazapine
eucalyptus and mirtazapine both increase sedation. Minor/Significance Unknown.
- modafinil
eucalyptus increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- morphine
morphine and eucalyptus both increase sedation. Minor/Significance Unknown.
- motherwort
eucalyptus and motherwort both increase sedation. Minor/Significance Unknown.
- moxonidine
eucalyptus and moxonidine both increase sedation. Minor/Significance Unknown.
- nabilone
eucalyptus and nabilone both increase sedation. Minor/Significance Unknown.
- nafcillin
nafcillin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- nalbuphine
nalbuphine and eucalyptus both increase sedation. Minor/Significance Unknown.
- nateglinide
eucalyptus increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- nefazodone
nefazodone will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- nelfinavir
nelfinavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- nevirapine
nevirapine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- nifedipine
nifedipine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- nilotinib
nilotinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- norepinephrine
eucalyptus increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- nortriptyline
nortriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.
- olanzapine
olanzapine and eucalyptus both increase sedation. Minor/Significance Unknown.
- opium tincture
opium tincture and eucalyptus both increase sedation. Minor/Significance Unknown.
- orphenadrine
orphenadrine and eucalyptus both increase sedation. Minor/Significance Unknown.
- oxazepam
oxazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- oxcarbazepine
oxcarbazepine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- oxycodone
oxycodone and eucalyptus both increase sedation. Minor/Significance Unknown.
- oxymorphone
oxymorphone and eucalyptus both increase sedation. Minor/Significance Unknown.
- paliperidone
paliperidone and eucalyptus both increase sedation. Minor/Significance Unknown.
- papaveretum
papaveretum and eucalyptus both increase sedation. Minor/Significance Unknown.
- papaverine
eucalyptus and papaverine both increase sedation. Minor/Significance Unknown.
- pentazocine
pentazocine and eucalyptus both increase sedation. Minor/Significance Unknown.
- pentobarbital
pentobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
pentobarbital and eucalyptus both increase sedation. Minor/Significance Unknown. - perphenazine
perphenazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- phendimetrazine
eucalyptus increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- phenobarbital
phenobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
phenobarbital and eucalyptus both increase sedation. Minor/Significance Unknown. - phentermine
eucalyptus increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- phenylephrine
eucalyptus increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- phenylephrine PO
eucalyptus increases and phenylephrine PO decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown. .
- phenytoin
phenytoin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- pholcodine
eucalyptus and pholcodine both increase sedation. Minor/Significance Unknown.
- pimozide
pimozide and eucalyptus both increase sedation. Minor/Significance Unknown.
- pioglitazone
eucalyptus increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- pirbuterol
eucalyptus increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- posaconazole
posaconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- prednisone
prednisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- primidone
primidone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
primidone and eucalyptus both increase sedation. Minor/Significance Unknown. - prochlorperazine
prochlorperazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- promethazine
promethazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- propylhexedrine
eucalyptus increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- protriptyline
protriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.
- quazepam
quazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- quetiapine
quetiapine and eucalyptus both increase sedation. Minor/Significance Unknown.
- quinupristin/dalfopristin
quinupristin/dalfopristin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- ramelteon
eucalyptus and ramelteon both increase sedation. Minor/Significance Unknown.
- repaglinide
eucalyptus increases effects of repaglinide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- rifapentine
rifapentine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- risperidone
risperidone and eucalyptus both increase sedation. Minor/Significance Unknown.
- ritonavir
ritonavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- rosiglitazone
eucalyptus increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- rufinamide
rufinamide will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- sage
eucalyptus and sage both increase sedation. Minor/Significance Unknown.
- salmeterol
eucalyptus increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- saxagliptin
eucalyptus increases effects of saxagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- scullcap
eucalyptus and scullcap both increase sedation. Minor/Significance Unknown.
- secobarbital
secobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
secobarbital and eucalyptus both increase sedation. Minor/Significance Unknown. - shepherd's purse
eucalyptus and shepherd's purse both increase sedation. Minor/Significance Unknown.
- sitagliptin
eucalyptus increases effects of sitagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- sodium oxybate
eucalyptus and sodium oxybate both increase sedation. Minor/Significance Unknown.
- sufentanil
sufentanil and eucalyptus both increase sedation. Minor/Significance Unknown.
- tapentadol
tapentadol and eucalyptus both increase sedation. Minor/Significance Unknown.
- temazepam
temazepam and eucalyptus both increase sedation. Minor/Significance Unknown.
- terbutaline
eucalyptus increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- thioridazine
thioridazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- thiothixene
thiothixene and eucalyptus both increase sedation. Minor/Significance Unknown.
- tolazamide
eucalyptus increases effects of tolazamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- tolbutamide
eucalyptus increases effects of tolbutamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- topiramate
topiramate will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- tramadol
tramadol and eucalyptus both increase sedation. Minor/Significance Unknown.
- trazodone
trazodone and eucalyptus both increase sedation. Minor/Significance Unknown.
- triazolam
triazolam and eucalyptus both increase sedation. Minor/Significance Unknown.
- triclofos
triclofos and eucalyptus both increase sedation. Minor/Significance Unknown.
- trifluoperazine
trifluoperazine and eucalyptus both increase sedation. Minor/Significance Unknown.
- trimipramine
trimipramine and eucalyptus both increase sedation. Minor/Significance Unknown.
- triprolidine
triprolidine and eucalyptus both increase sedation. Minor/Significance Unknown.
- verapamil
verapamil will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- vildagliptin
eucalyptus increases effects of vildagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.
- voriconazole
voriconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- xylometazoline
eucalyptus increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- yohimbine
eucalyptus increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.
- zafirlukast
zafirlukast will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
- ziconotide
eucalyptus and ziconotide both increase sedation. Minor/Significance Unknown.
- ziprasidone
ziprasidone and eucalyptus both increase sedation. Minor/Significance Unknown.
Adverse Effects
Allergic rxns
Severe AEs if oil is taken PO: abd pain, cyanosis, dyspnea, ataxia, hypotension, arrhythmias, multiorgan failure
Warnings
Contraindications
Acute intermittent porphyria
Cautions
Do NOT ingest oil - severe, potentially fatal toxicity
Diabetes, hypoglycemia
Pregnancy & Lactation
Pregnancy Category: avoid
Lactation: avoid
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Elicits anti-inflammatory effect by interacting with OH- radicals; interferes with leukocyte activation